Neurocrine Biosciences to Present at the 41st Annual J.P. Morgan Healthcare Conference
Neurocrine Biosciences (Nasdaq: NBIX) will present at the 41st Annual J.P. Morgan Healthcare Conference on January 9, 2023, at 11:15 a.m. PT in San Francisco. CEO Kevin Gorman will lead the presentation, which can be accessed via a live webcast on the company's website, www.neurocrine.com. A replay will be available approximately one hour post-event and archived for a month. Neurocrine focuses on developing treatments for neurological and neuroendocrine disorders, with FDA-approved therapies for tardive dyskinesia, Parkinson's disease, endometriosis, and uterine fibroids in its portfolio.
- None.
- None.
SAN DIEGO, Jan. 3, 2023 /PRNewswire/ -- Neurocrine Biosciences, Inc. (Nasdaq: NBIX) will present at the 41st Annual J.P. Morgan Healthcare Conference at 11:15 a.m. Pacific Time on Monday Jan. 9, 2023 in San Francisco. Kevin Gorman, Chief Executive Officer, will present at the conference.
The live presentation will be webcast and may be accessed on the Company's website under Investors at www.neurocrine.com. A replay of the presentation will be available on the website approximately one hour after the conclusion of the events and will be archived for approximately one month.
Neurocrine Biosciences is a neuroscience-focused, biopharmaceutical company with a simple purpose: to relieve suffering for people with great needs, but few options. We are dedicated to discovering and developing life-changing treatments for patients with under-addressed neurological, neuroendocrine, and neuropsychiatric disorders. The company's diverse portfolio includes FDA-approved treatments for tardive dyskinesia, Parkinson's disease, endometriosis* and uterine fibroids*, as well as over a dozen mid-to-late-stage clinical programs in multiple therapeutic areas. For three decades, we have applied our unique insight into neuroscience and the interconnections between brain and body systems to treat complex conditions. We relentlessly pursue medicines to ease the burden of debilitating diseases and disorders, because you deserve brave science. For more information, visit neurocrine.com, and follow the company on LinkedIn, Twitter, and Facebook. (*in collaboration with AbbVie)
View original content to download multimedia:https://www.prnewswire.com/news-releases/neurocrine-biosciences-to-present-at-the-41st-annual-jp-morgan-healthcare-conference-301712699.html
SOURCE Neurocrine Biosciences, Inc.
FAQ
When is Neurocrine Biosciences presenting at the J.P. Morgan Healthcare Conference?
Who is presenting for Neurocrine Biosciences at the conference?
How can I access the Neurocrine Biosciences presentation?
Will there be a replay of the Neurocrine Biosciences conference presentation?
What does Neurocrine Biosciences focus on?
